Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 118

1.

Use of influenza antivirals in patients hospitalized in Hong Kong, 2000-2015.

Cowling BJ, Chui CSL, Lim WW, Wu P, Hui CKM, Peiris JSM, Chan EW.

PLoS One. 2018 Jan 19;13(1):e0190306. doi: 10.1371/journal.pone.0190306. eCollection 2018.

2.

Synergistic effects of influenza and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) can be eliminated by the use of influenza therapeutics: experimental evidence for the multi-hit hypothesis.

Sadasivan S, Sharp B, Schultz-Cherry S, Smeyne RJ.

NPJ Parkinsons Dis. 2017 May 23;3:18. doi: 10.1038/s41531-017-0019-z. eCollection 2017.

3.

Single cell imaging and quantification of TDP-43 and α-synuclein intercellular propagation.

Peled S, Sade D, Bram Y, Porat Z, Kreiser T, Mimouni M, Lichtenstein A, Segal D, Gazit E.

Sci Rep. 2017 Mar 28;7(1):544. doi: 10.1038/s41598-017-00657-z.

4.

Arctigenin Attenuates Learning and Memory Deficits through PI3k/Akt/GSK-3β Pathway Reducing Tau Hyperphosphorylation in Aβ-Induced AD Mice.

Qi Y, Dou DQ, Jiang H, Zhang BB, Qin WY, Kang K, Zhang N, Jia D.

Planta Med. 2017 Jan;83(1-02):51-56. doi: 10.1055/s-0042-107471. Epub 2016 May 25.

PMID:
27224270
5.

Adamantane - A Lead Structure for Drugs in Clinical Practice.

Spilovska K, Zemek F, Korabecny J, Nepovimova E, Soukup O, Windisch M, Kuca K.

Curr Med Chem. 2016;23(29):3245-3266. Review.

PMID:
27222266
6.

Redox Imbalance and Viral Infections in Neurodegenerative Diseases.

Limongi D, Baldelli S.

Oxid Med Cell Longev. 2016;2016:6547248. doi: 10.1155/2016/6547248. Epub 2016 Mar 27. Review.

7.

Early-Life Factors and Risk of Parkinson's Disease: A Register-Based Cohort Study.

Liu B, Chen H, Fang F, Tillander A, Wirdefeldt K.

PLoS One. 2016 Apr 15;11(4):e0152841. doi: 10.1371/journal.pone.0152841. eCollection 2016.

8.

Effects of antiviral treatment on influenza-related complications over four influenza seasons: 2006-2010.

Spagnuolo PJ, Zhang M, Xu Y, Han J, Liu S, Liu J, Lichtveld M, Shi L.

Curr Med Res Opin. 2016 Aug;32(8):1399-407. doi: 10.1080/03007995.2016.1176016. Epub 2016 May 12.

PMID:
27052817
9.

Causes of Death Associated With Prolonged TV Viewing: NIH-AARP Diet and Health Study.

Keadle SK, Moore SC, Sampson JN, Xiao Q, Albanes D, Matthews CE.

Am J Prev Med. 2015 Dec;49(6):811-21. doi: 10.1016/j.amepre.2015.05.023. Epub 2015 Jul 26.

10.

Neuroprotective effects of ginkgetin against neuroinjury in Parkinson's disease model induced by MPTP via chelating iron.

Wang YQ, Wang MY, Fu XR, Peng-Yu, Gao GF, Fan YM, Duan XL, Zhao BL, Chang YZ, Shi ZH.

Free Radic Res. 2015;49(9):1069-80. doi: 10.3109/10715762.2015.1032958. Epub 2015 Jul 1.

PMID:
25968939
11.

Associations between depression and all-cause and cause-specific risk of death: a retrospective cohort study in the Veterans Health Administration.

Zivin K, Yosef M, Miller EM, Valenstein M, Duffy S, Kales HC, Vijan S, Kim HM.

J Psychosom Res. 2015 Apr;78(4):324-31. doi: 10.1016/j.jpsychores.2015.01.014. Epub 2015 Feb 4.

PMID:
25697585
12.

Medical and molecular perspectives into a forgotten epidemic: encephalitis lethargica, viruses, and high-throughput sequencing.

Tappe D, Alquezar-Planas DE.

J Clin Virol. 2014 Oct;61(2):189-95. doi: 10.1016/j.jcv.2014.07.013. Epub 2014 Jul 30. Review.

PMID:
25129855
13.

Inflammation-sleep interface in brain disease: TNF, insulin, orexin.

Clark IA, Vissel B.

J Neuroinflammation. 2014 Mar 21;11:51. doi: 10.1186/1742-2094-11-51. Review.

14.

Acute respiratory distress syndrome: A rare presentation of amantadine toxicity.

Cattoni J, Parekh R.

Am J Case Rep. 2014 Jan 2;15:1-3. doi: 10.12659/AJCR.889931. eCollection 2014.

15.

Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.

Hammer C, Stepniak B, Schneider A, Papiol S, Tantra M, Begemann M, Sirén AL, Pardo LA, Sperling S, Mohd Jofrry S, Gurvich A, Jensen N, Ostmeier K, Lühder F, Probst C, Martens H, Gillis M, Saher G, Assogna F, Spalletta G, Stöcker W, Schulz TF, Nave KA, Ehrenreich H.

Mol Psychiatry. 2014 Oct;19(10):1143-9. doi: 10.1038/mp.2013.110. Epub 2013 Sep 3.

PMID:
23999527
16.

Treatment implications of the altered cytokine-insulin axis in neurodegenerative disease.

Clark IA, Vissel B.

Biochem Pharmacol. 2013 Oct 1;86(7):862-71. doi: 10.1016/j.bcp.2013.07.030. Epub 2013 Aug 9. Review.

PMID:
23939185
17.

The Demise of Poskanzer and Schwab's Influenza Theory on the Pathogenesis of Parkinson's Disease.

Estupinan D, Nathoo S, Okun MS.

Parkinsons Dis. 2013;2013:167843. doi: 10.1155/2013/167843. Epub 2013 Jun 11.

18.

Leucine-rich repeat kinase 2 (LRRK2)-deficient rats exhibit renal tubule injury and perturbations in metabolic and immunological homeostasis.

Ness D, Ren Z, Gardai S, Sharpnack D, Johnson VJ, Brennan RJ, Brigham EF, Olaharski AJ.

PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013.

19.

Flu-like symptoms and associated immunological response following therapy with botulinum toxins.

Baizabal-Carvallo JF, Jankovic J, Feld J.

Neurotox Res. 2013 Aug;24(2):298-306. doi: 10.1007/s12640-013-9400-9. Epub 2013 May 16.

PMID:
23677449
20.

Infections as a risk factor for Parkinson's disease: a case-control study.

Vlajinac H, Dzoljic E, Maksimovic J, Marinkovic J, Sipetic S, Kostic V.

Int J Neurosci. 2013 May;123(5):329-32. doi: 10.3109/00207454.2012.760560. Epub 2013 Feb 4.

PMID:
23270425

Supplemental Content

Loading ...
Support Center